ArticleImmunoHorizons2026
Presentation of the protective epitope in a Chlamydia muridarum MOMP vaccine is dependent on γ-interferon-inducible lysosomal thiol reductase (GILT).
Article in ImmunoHorizons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The Chlamydia outer membrane complex has approximately 20 cysteine-rich proteins, including the major outer membrane protein (MOMP) with 8 cysteines. The enzyme γ-interferon-inducible lysosomal thiol reductase (GILT) is expressed constitutively in lysosomes of antigen presenting cells and reproductive tract epithelial cells. GILT catalyzes disulfide bond reduction during protein degradation that generates T cell epitopes. To evaluate the role that GILT plays in chlamydial infections, C57BL/6 WT mice and mice deficient in Ifi30 (GILT-KO) were challenged vaginally with Chlamydia muridarum (Cm). Both were equally susceptible to the Cm infection and upper genital tract pathology. To assess GILT's role in processing MOMP epitopes, WT and GILT-KO mice were immunized with native (nMOMP) or recombinant (rMOMP) antigens. In both strains vaccination with Cm nMOMP and rMOMP induced a similar spectrum of MOMP-specific antibodies. nMOMP immunization generated higher neutralizing antibody titers than rMOMP, but neutralizing titers did not differ between mouse strains. Splenocytes from vaccinated WT and GILT-KO mice recognized T cell epitopes in nMOMP, and to a lesser extent with rMOMP. No protection was seen in either WT or GILT-KO mice vaccinated with rMOMP based on intensity and duration of vaginal shedding, upper genital tract pathology, and fertility post-infection. nMOMP vaccination protected WT mice based on attenuated bacterial shedding and preserved fertility but nMOMP-vaccinated GILT-KO mice were not protected. The failure of nMOMP vaccination in GILT-KO mice revealed that GILT-dependent MOMP epitope processing was outcome determinative and identified a pan-serovar, likely protective, class II T cell epitope in MOMP constant domain 3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.